Lexology August 19, 2020
Ropes & Gray LLP

On July 29, 2020, the U.S. Food and Drug Administration issued final guidance on the regulation of devices with multiple functions, Multiple Function Device Products: Policy and Considerations (“final guidance”). This guidance, which finalizes a draft issued April 27, 2018, implements a requirement of the 21st Century Cures Act (“Cures Act”) that prohibits FDA from directly regulating non-“device” software functions in digital health products. Like the draft, the final guidance covers more than just software functions, however, and instead addresses all products that include both device and non-device functions. Any manufacturer of a product that includes both device and non-device functions should therefore pay close attention to this guidance.

Key Updates to the Draft Guidance

The final guidance is largely similar to...

Today's Sponsors

Tridiuum
Elevation Health Consulting
Augmedix

Today's Sponsors

PartsSource
TripleTree

Today's Sponsor

holon

2020-08-20T21:18:42-04:00